Is neuroblastoma screening evaluation needed and feasible?
Despite the five million children who have been screened for neuroblastoma in Japan through detection of catecholamine metabolites, it is still uncertain whether screening for this disease is beneficial. The Japanese study has clearly indicated that screening at 6 months or earlier leads to heavy ov...
Main Authors: | Estève, J., Parker, L., Roy, P., Herrmann, F., Duffy, S., Frappaz, D., Lasset, C., Hill, C., Sancho-Garnier, H., Michaelis, J. |
---|---|
Format: | Online |
Language: | English |
Published: |
1995
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033839/ |
Similar Items
-
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
by: Combaret, V., et al.
Published: (1997) -
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.
by: Favrot, M. C., et al.
Published: (1986) -
Feasibility of implementing the ‘Screening for Distress and Referral Need’ process in 23 Dutch hospitals
by: van Nuenen, F. M., et al.
Published: (2016) -
Imaging neuroblastoma: what the radiologist needs to know
by: McCarville, M.B.
Published: (2011) -
Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
by: Babich, J. W., et al.
Published: (1996)